The fight against malaria in Togo has taken a new step forward. On Monday, September 1, the Ministry of Health and Public Hygiene officially added the R21/Matrix malaria vaccine to the country’s Expanded Program on Immunization. The vaccine is one of two malaria shots prequalified by the World Health Organization (WHO).
The vaccine, provided free of charge, will be administered to children starting at five months of age. It requires four doses, spaced out until the child reaches 15 months. According to the government, while it protects against clinical forms of the disease, the R21/Matrix mainly complements existing prevention strategies such as the triennial nationwide distribution of insecticide-treated bed nets, preventive treatment for pregnant women and children in high-transmission areas, rapid diagnostic tests, and intermittent preventive treatment for infants.
Despite years of efforts, malaria remains a heavy burden in Togo. In 2023 alone, the country recorded 2.1 million cases and 993 deaths, 70% of which were children under five.
“This vaccine will help save many lives and significantly reduce the socio-economic impact of this disease on families and communities,” said Kokou Wotobé, Secretary General of the Health Ministry. He also urged vigilance, especially during the ongoing rainy season across several regions of the country.
An official launch ceremony is scheduled for Thursday, September 4, in Sokodé, located in the Central Region. This will be followed by a nationwide awareness campaign to reassure the public.
The decision comes after a successful two-year pilot phase in Malawi, Kenya, and Ghana, involving thousands of children. Since 2024, twenty African countries have already rolled out the malaria vaccine.
Togo introduces malaria vaccine into national immunization program
